Robert W. Prosser
Columbia University
15 Papers
35 Citations
Robert W. Prosser is an academic researcher from Columbia University. The author has contributed to research in topics: Embryonic stem cell & Biology. The author has an hindex of 9, co-authored 14 publications.
Chat about Author
Papers
Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants
Daniel Paull,Valentina Emmanuele,Keren A. Weiss,Nathan R. Treff,Latoya Stewart,Haiqing Hua,Haiqing Hua,Matthew Zimmer,David J. Kahler,Robin Goland,Scott Noggle,Robert W. Prosser,Michio Hirano,Mark V. Sauer,Dieter Egli +14 more
TL;DR: The potential of nuclear genome transfer between unfertilized oocytes of two donors to prevent the transmission of mitochondrial mutations is demonstrated and mitochondrial respiratory chain enzyme activities and oxygen consumption rates are indistinguishable from controls.
256
Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes
Mitsutoshi Yamada,Valentina Emmanuele,Maria J. Sanchez-Quintero,Bruce Sun,Gregory Lallos,Daniel Paull,Matthew Zimmer,Shardonay Pagett,Robert W. Prosser,Mark V. Sauer,Michio Hirano,Dieter Egli,Dieter Egli +12 more
TL;DR: Using human mitochondrial replacement stem cell lines, it is shown that, even though the low levels of heteroplasmy introduced into human oocytes by mitochondrial carryover during nuclear transfer often vanish, they can sometimes instead result in mtDNA genotypic drift and reversion to the original genotype.
175
Further Studies Of Inhibitors Of In Vitro Mammalian Oocyte Maturation
TL;DR: Studies of luteinizing hormone (LH)-mediated serum inhibition and of follicular fluid and granulosa cell inhibition of in vitro porcine, ewe, and cow oocyte meiotic maturation have been carried out and it is postulated that the follicular fluids inhibitor may be derived from the larger serum molecule by an action of LH within an intermediate cell type.
35
Optimization of IVF pregnancy outcomes with donor spermatozoa
TL;DR: While ICSI does not need to be categorically instituted when using donor spermatozoa in IVF, patients should be counseled that conversion from insemination to I CSI may be recommended based on low post-processing motility.
The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation
TL;DR: The addition of NETA does not attenuate COH in women undergoing IVF, and no differences were noted in days of stimulation, peak estradiol (E2) level attained, peak E2-to-oocyte ratio, dosage of exogenous gonadotropins, number of aspirated oocytes, fertilization rate, or oocyte and preembryo quality.